Cargando…
New Onset Atrial Fibrillation in STEMI Patients: Main Prognostic Factors and Clinical Outcome
The indications for the treatment of patients with known atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) are clear, while less is available about the management of new-onset AF (NOAF) during ST-segment elevation myocardial infarction (STEMI). The aim of this study is to...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955053/ https://www.ncbi.nlm.nih.gov/pubmed/36832101 http://dx.doi.org/10.3390/diagnostics13040613 |
_version_ | 1784894262294347776 |
---|---|
author | Dal Zotto, Beatrice Barbieri, Lucia Tumminello, Gabriele Saviano, Massimo Gentile, Domitilla Lucreziotti, Stefano Frattini, Loredana Tarricone, Diego Carugo, Stefano |
author_facet | Dal Zotto, Beatrice Barbieri, Lucia Tumminello, Gabriele Saviano, Massimo Gentile, Domitilla Lucreziotti, Stefano Frattini, Loredana Tarricone, Diego Carugo, Stefano |
author_sort | Dal Zotto, Beatrice |
collection | PubMed |
description | The indications for the treatment of patients with known atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) are clear, while less is available about the management of new-onset AF (NOAF) during ST-segment elevation myocardial infarction (STEMI). The aim of this study is to evaluate mortality and clinical outcome of this high-risk subgroup of patients. We analyzed 1455 consecutive patients undergoing PCI for STEMI. NOAF was detected in 102 subjects, 62.7% males, with a mean age of 74.8 ± 10.6 years. The mean ejection fraction (EF) was 43.5 ± 12.1% and the mean atrial volume was increased (58 ± 20.9 mL). NOAF occurred mainly in the peri-acute phase and had a very variable duration (8.1 ± 12.5 min). During hospitalization, all the patients were treated with enoxaparin, but only 21.6% of them were discharged with long term oral anticoagulation. The majority of patients had a CHA2DS2-VASc score >2 and a HAS-BLED score of 2 or 3. The in-hospital mortality was 14.2%, while the 1-year mortality was 17.2% and long-term mortality 32.1% (median follow-up 1820 days). We identified age as an independent predictor of mortality both at short- and long-term follow-ups, while EF was the only independent predictor for in-hospital mortality and arrhythmia duration for 1-year mortality. At the 1-year follow-up, we recorded three ischemic strokes and no bleeding complications. |
format | Online Article Text |
id | pubmed-9955053 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99550532023-02-25 New Onset Atrial Fibrillation in STEMI Patients: Main Prognostic Factors and Clinical Outcome Dal Zotto, Beatrice Barbieri, Lucia Tumminello, Gabriele Saviano, Massimo Gentile, Domitilla Lucreziotti, Stefano Frattini, Loredana Tarricone, Diego Carugo, Stefano Diagnostics (Basel) Article The indications for the treatment of patients with known atrial fibrillation (AF) undergoing percutaneous coronary intervention (PCI) are clear, while less is available about the management of new-onset AF (NOAF) during ST-segment elevation myocardial infarction (STEMI). The aim of this study is to evaluate mortality and clinical outcome of this high-risk subgroup of patients. We analyzed 1455 consecutive patients undergoing PCI for STEMI. NOAF was detected in 102 subjects, 62.7% males, with a mean age of 74.8 ± 10.6 years. The mean ejection fraction (EF) was 43.5 ± 12.1% and the mean atrial volume was increased (58 ± 20.9 mL). NOAF occurred mainly in the peri-acute phase and had a very variable duration (8.1 ± 12.5 min). During hospitalization, all the patients were treated with enoxaparin, but only 21.6% of them were discharged with long term oral anticoagulation. The majority of patients had a CHA2DS2-VASc score >2 and a HAS-BLED score of 2 or 3. The in-hospital mortality was 14.2%, while the 1-year mortality was 17.2% and long-term mortality 32.1% (median follow-up 1820 days). We identified age as an independent predictor of mortality both at short- and long-term follow-ups, while EF was the only independent predictor for in-hospital mortality and arrhythmia duration for 1-year mortality. At the 1-year follow-up, we recorded three ischemic strokes and no bleeding complications. MDPI 2023-02-07 /pmc/articles/PMC9955053/ /pubmed/36832101 http://dx.doi.org/10.3390/diagnostics13040613 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Dal Zotto, Beatrice Barbieri, Lucia Tumminello, Gabriele Saviano, Massimo Gentile, Domitilla Lucreziotti, Stefano Frattini, Loredana Tarricone, Diego Carugo, Stefano New Onset Atrial Fibrillation in STEMI Patients: Main Prognostic Factors and Clinical Outcome |
title | New Onset Atrial Fibrillation in STEMI Patients: Main Prognostic Factors and Clinical Outcome |
title_full | New Onset Atrial Fibrillation in STEMI Patients: Main Prognostic Factors and Clinical Outcome |
title_fullStr | New Onset Atrial Fibrillation in STEMI Patients: Main Prognostic Factors and Clinical Outcome |
title_full_unstemmed | New Onset Atrial Fibrillation in STEMI Patients: Main Prognostic Factors and Clinical Outcome |
title_short | New Onset Atrial Fibrillation in STEMI Patients: Main Prognostic Factors and Clinical Outcome |
title_sort | new onset atrial fibrillation in stemi patients: main prognostic factors and clinical outcome |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955053/ https://www.ncbi.nlm.nih.gov/pubmed/36832101 http://dx.doi.org/10.3390/diagnostics13040613 |
work_keys_str_mv | AT dalzottobeatrice newonsetatrialfibrillationinstemipatientsmainprognosticfactorsandclinicaloutcome AT barbierilucia newonsetatrialfibrillationinstemipatientsmainprognosticfactorsandclinicaloutcome AT tumminellogabriele newonsetatrialfibrillationinstemipatientsmainprognosticfactorsandclinicaloutcome AT savianomassimo newonsetatrialfibrillationinstemipatientsmainprognosticfactorsandclinicaloutcome AT gentiledomitilla newonsetatrialfibrillationinstemipatientsmainprognosticfactorsandclinicaloutcome AT lucreziottistefano newonsetatrialfibrillationinstemipatientsmainprognosticfactorsandclinicaloutcome AT frattiniloredana newonsetatrialfibrillationinstemipatientsmainprognosticfactorsandclinicaloutcome AT tarriconediego newonsetatrialfibrillationinstemipatientsmainprognosticfactorsandclinicaloutcome AT carugostefano newonsetatrialfibrillationinstemipatientsmainprognosticfactorsandclinicaloutcome |